A5050048738- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Genetic factors in colorectal cancer
- Cancer Immunotherapy and Biomarkers
- Global Health Workforce Issues
- Global Health and Surgery
- Gastric Cancer Management and Outcomes
- Patient Dignity and Privacy
- Cancer survivorship and care
- Colorectal and Anal Carcinomas
- Palliative Care and End-of-Life Issues
- Inflammatory mediators and NSAID effects
- Inflammatory Biomarkers in Disease Prognosis
- Advances in Oncology and Radiotherapy
- Metabolism, Diabetes, and Cancer
- Microscopic Colitis
- Frailty in Older Adults
- Diversity and Career in Medicine
- Inflammatory Bowel Disease
- Nutrition and Health in Aging
- Cardiac, Anesthesia and Surgical Outcomes
- Cancer Risks and Factors
Massachusetts General Hospital
2022-2024
Harvard University
2022-2024
Suzuki (Japan)
2023
Society for Community Health Awareness Research and Action
2022-2023
Mass General Brigham
2022
University of Pittsburgh Medical Center
2022
Micropapillary carcinoma (MPC) is a recognised WHO variant of colonic (CC), although little known about its prognosis, immune microenvironment and molecular alterations. We investigated clinical, pathological immunological characteristics.
For universal surgical, obstetric, trauma, and anesthesia care by 2030, the Lancet Commission on Global Surgery (LCoGS) suggested tracking six indicators. We reviewed academic policy literature to investigate current state of LCoGS indicators in India. There was limited primary data for access timely essential surgery, risk impoverishing catastrophic health expenditures due though some modeled estimates are present. Surgical specialist workforce heterogeneous across different levels care,...
Objective: To create a recurrence prediction value (RPV) of high-risk factor and identify the patients with high risk cancer recurrence. Background: There are several factors known to lead poor outcomes. Weighting each based on their association increased can provide more precise understanding Methods: We performed multi-institutional international retrospective analysis stage II colon who underwent surgery from 2010 2020. Patient data database were used as Training data, completely separate...
Introduction There is emerging evidence that metformin may have a protective effect in patients with cancer. However, its current locally advanced rectal cancer (LARC) inconclusive. We aim to assess the of on long-term outcomes LARC who received neoadjuvant therapy and surgical resection. Methods A retrospective review 324 nonmetastatic major resection from 2004 2018. were 27 before surgery 297 did not receive metformin. Results Metformin users associated significantly higher age, BMI, ASA...
Background Our objective is to identify factors for inpatient death in patients undergoing resection colorectal cancer (CRC). Study Design Unmatched 1:3 case-control study of surgically resected CRC at a tertiary care institution between 2004 and 2018. Variables multivariate analysis were selected using tetrachoric correlation followed by least absolute shrinkage selection operator (LASSO) penalized regression model. Results A total 140 included (N = 35 who died inpatient, N 105 did not...